Nitroprusside: Difference between revisions
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
==Category== | ==Category== | ||
Cyanides;Vasodilators;Coordination compounds;World Health Organization essential medicines;Ironcompounds;Nitrosylcompounds;Cardiovascular Drugs | [[Cyanides]];[[Vasodilators]];[[Coordination compounds]];[[World Health Organization essential medicines]];[[Ironcompounds]];[[Nitrosylcompounds]];[[Cardiovascular Drugs]] | ||
==NITROPRESS (sodium nitroprusside) injection, solution, concentrate == | ==NITROPRESS (sodium nitroprusside) injection, solution, concentrate == | ||
| Line 27: | Line 27: | ||
''' [[Nitroprusside indications and usage|Indications and Usage]]''' | ''' [[Nitroprusside indications and usage|Indications and Usage]]''' | ||
'''| [[Nitroprusside dosage and administration|Dosage and Administration]]''' | '''| [[Nitroprusside dosage and administration|Dosage and Administration]]''' | ||
'''| [[Nitroprusside contraindications|Contraindications]]''' | '''| [[Nitroprusside contraindications|Contraindications]]''' | ||
'''| [[Nitroprusside warnings and precautions|Warnings and Precautions]]''' | '''| [[Nitroprusside warnings and precautions|Warnings and Precautions]]''' | ||
| Line 39: | Line 38: | ||
'''| [[Nitroprusside clinical studies|Clinical Studies]]''' | '''| [[Nitroprusside clinical studies|Clinical Studies]]''' | ||
'''| [[Nitroprusside how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Nitroprusside how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Nitroprusside labels and packages|Labels and Packages]]''' | '''| [[Nitroprusside labels and packages|Labels and Packages]]''' | ||
| Line 48: | Line 46: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cyanides]] | [[Category:Cyanides]] | ||
Revision as of 16:58, 27 February 2014
| Nitroprusside |
|---|
| NITROPRESS® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Nitroprusside |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Nitroprusside, click here.
Synonyms / Brand Names: NITROPRESS®
 |
Overview
Sodium nitroprusside is an inorganic compound with the formula Na2[Fe(CN)5NO], usually encountered as the dihydrate, Na2[Fe(CN)5NO]·2H2O.[1] This red-colored sodium salt dissolves in water ethanol to give solutions containing the free complex dianion [Fe(CN)5NO]2−.
This compound is used as a drug. In this role it is abbreviated SNP, and it has tradenames like Nitropress. It acts as a drug by releasing nitric oxide; it belongs to the class of NO-releasing drugs as a result. This drug is used as a vasodilator to reduce blood pressure. It has also been used to treat other conditions, and it has been successfully tried as treatment for schizophrenia. Sodium nitroprusside is also used as an analytical reagent for the detection of methyl ketones, and for the detection of amines that are often found in illicit drugs.
Category
Cyanides;Vasodilators;Coordination compounds;World Health Organization essential medicines;Ironcompounds;Nitrosylcompounds;Cardiovascular Drugs
NITROPRESS (sodium nitroprusside) injection, solution, concentrate
Label Title
Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Labels and Packages
Mechanism of Action
References
- ↑ A. R. Butler, I. L. Megson (2002). "Non-Heme Iron Nitrosyls in Biology". Chemical Reviews. 102 (4): 1155–1165. doi:10.1021/cr000076d.